Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2023 Earnings Call Transcript

Back on the retail side, again, I come back to just these four pillars we’re focused on, led by fiscal availability is just we’re in more stores on more shelves both Seresto, Advantage, leveraging those brands and also at more price points. So when we introduced the new Advantage brands at more price points. So price is another factor. Increasing share of voice, more campaigns, more targeted digital with those campaigns as another factor. And then bringing innovation. We’ve got Ellen and Bobby, they’ve got a whole arm of innovation and links to that. So as a whole, we’ve increased our share this quarter on retail, and we continue to see this as a significant driver. And as we launch Adtab over in Europe, the same thing applies as well to the international markets.

So, excited about that.

Katy Grissom: Great. I believe that was our last caller question. So Jeff, would you like to close this?

Jeff Simmons: Yes. So thank you for your interest. Again, another quarter, we believe, of proof and progress on our strategy, delivering above our expectations, raising the guidance for the full year. We see our company returning to growth in the second half of this year and heading into the next era of significant innovation and growth, starting with the innovation that’s approved, that is ramping as we move forward today. Again, we are more capable today than we’ve ever been with our ERP stand-up complete, Seresto behind us, and now our focus is on delivering today while preparing also for these historical innovations that are coming in as we head into 2024. Thanks for your interest. We look forward to engaging with you throughout the quarter.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect.